-
Treatment for Multiple System Atrophy Shows Promise for Parkinson’s
Prana Biotechnology’s investigational compound PBT434 prevented neuronal loss and improved motor function in an animal model of multiple system atrophy (MSA), a condition that shares many of Parkinson’s motor symptoms, according to preclinical data.
The data will be presented at the International Congress of Parkinson’s Disease and Movement Disorders, taking place Oct. 5-9 in Hong Kong. Click here to read more on this story.
What do you think about this news?
Sorry, there were no replies found.
Log in to reply.